UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000021057
Receipt number R000023986
Scientific Title A prospective, multicenter, observational study: validity of modified treatment strategy for neonatal jaundice in Japan
Date of disclosure of the study information 2016/04/01
Last modified on 2020/06/23 15:56:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A prospective, multicenter, observational study: validity of modified treatment strategy for neonatal jaundice in Japan

Acronym

Validity of modified treatment strategy for neonatal jaundice

Scientific Title

A prospective, multicenter, observational study: validity of modified treatment strategy for neonatal jaundice in Japan

Scientific Title:Acronym

Validity of modified treatment strategy for neonatal jaundice

Region

Japan


Condition

Condition

neonatal jaundice

Classification by specialty

Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the validity of modified treatment strategy for neonatal jaundice

Basic objectives2

Others

Basic objectives -Others

To clarify the duration of phototherapy and the rate of exchange transfusion in newborn period, and the rate of kernicterus and neurodevelopment mobidity at 18 months corrected age

Trial characteristics_1

Confirmatory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

The rate of kernicterus and neurodevelopmental mobidity at 18 months corrected age

Key secondary outcomes

The duration of phototherapy and the rate of exchange transfusion


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

1 days-old <=

Age-upper limit

540 days-old >

Gender

Male and Female

Key inclusion criteria

newborns treated for neonatal jaundice during study period

Key exclusion criteria

patients without consent from parents

Target sample size

6000


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Ichiro Morioka

Organization

Kobe University

Division name

Department of pediatrics

Zip code


Address

7-5-2, Kusunoki-cho, Chuo-ku, Kobe

TEL

81-78-382-6090

Email

ichim@med.kobe-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Ichiro Morioka

Organization

Kobe University

Division name

Department of pediatrics

Zip code


Address

7-5-2, Kusunoki-cho, Chuo-ku, Kobe

TEL

81-78-382-6090

Homepage URL


Email

ichim@med.kobe-u.ac.jp


Sponsor or person

Institute

Kobe University

Institute

Department

Personal name



Funding Source

Organization

Japan society for the promotion of science

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

神戸大学医学部附属病院(兵庫県)、日本大学板橋病院小児科(東京)、香川大学病院(香川県)、加古川西市民病院(兵庫県)、兵庫県立こども病院(兵庫県)、姫路赤十字病院(兵庫県)、愛仁会高槻病院(大阪府)、愛仁会千船病院(大阪府)、済生会兵庫県病院(兵庫県)


Other administrative information

Date of disclosure of the study information

2016 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

under study

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 04 Month 01 Day

Date of IRB

2017 Year 11 Month 17 Day

Anticipated trial start date

2015 Year 04 Month 01 Day

Last follow-up date

2020 Year 03 Month 31 Day

Date of closure to data entry

2020 Year 12 Month 31 Day

Date trial data considered complete

2020 Year 12 Month 31 Day

Date analysis concluded

2021 Year 03 Month 31 Day


Other

Other related information

Study design: Cohort study

Enrollment: Preterm infants admitted in our NICUs between April 2015 to March 2020, who fulfilled our inclusion criteria

Major outcome: The rate of kernicterus and neurodevelopmental mobidity at 18 months corrected age (Head MRI, Audiotory brainstem response)


Management information

Registered date

2016 Year 02 Month 16 Day

Last modified on

2020 Year 06 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023986


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name